Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Clin J Am Soc Nephrol. 2013 Jan;8(1):51-8. doi: 10.2215/CJN.05140512. Epub 2012 Oct 18.
Antiglomerular basement membrane autoantibodies are pathogenic in antiglomerular basement membrane disease with two major epitopes, E(A) and E(B), on α3 chain of type IV collagen. This study investigated the epitope spectrum of antiglomerular basement membrane autoantibodies, aiming to identify the association between epitope specificity and kidney injury.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All 108 patients with antiglomerular basement membrane disease and complete clinical data were divided into three groups according to renal dysfunction: mild group (n=20) with serum creatitine≤1.5 mg/dl; moderate group (n=22) with serum creatinine=1.5-6.8 mg/dl; severe group (n=66) with serum creatitine≥6.8 mg/dl. Epitope spectrums of antibodies were determined by ELISA, and their associations with kidney damage were analyzed. Sequential serum samples in 40 patients were examined during disease courses.
E(A) and E(B) were recognized in 79.6% and 72.2% of patients, respectively. E(A) and E(B) reactions were the lowest in the mild group and higher in the moderate group (E(A): 35.0% versus 81.8%, P=0.002; E(B): 15.0% versus 68.2%, P=0.001). They were the highest in the severe group (E(A): 92.4%, P=0.31; E(B): 90.9%, P=0.02). Close association was observed between renal injury and E(A) and E(B) reactions. Multivariate Cox regression analysis showed that E(B) reaction was an independent risk factor for renal failure (hazard ratio=6.91, P=0.02). The recognition for non-E(AB) remained low among groups. No augmentation of epitope spectrum was shown in serial serum samples.
Intramolecular epitope spreading might occur before the onset of human antiglomerular basement membrane disease. The autoimmunity to E(A) and E(B), especially E(B), was crucial for kidney dysfunction.
抗肾小球基底膜自身抗体在抗肾小球基底膜病中具有致病性,其靶抗原是Ⅳ型胶原α3 链上的两个主要表位 E(A)和 E(B)。本研究旨在探讨抗肾小球基底膜自身抗体的表位谱,以确定表位特异性与肾脏损伤之间的关系。
设计、地点、参与者和测量方法:所有 108 例抗肾小球基底膜病患者,均具有完整的临床资料,根据肾功能障碍分为三组:轻度组(n=20),血清肌酐≤1.5mg/dl;中度组(n=22),血清肌酐=1.5-6.8mg/dl;重度组(n=66),血清肌酐≥6.8mg/dl。通过 ELISA 法测定抗体的表位谱,并分析其与肾脏损害的关系。对 40 例患者的连续血清样本进行了检测。
E(A)和 E(B)在 79.6%和 72.2%的患者中被识别。E(A)和 E(B)反应在轻度组中最低,在中度组中较高(E(A):35.0%比 81.8%,P=0.002;E(B):15.0%比 68.2%,P=0.001)。在重度组中最高(E(A):92.4%,P=0.31;E(B):90.9%,P=0.02)。肾脏损伤与 E(A)和 E(B)反应密切相关。多变量 Cox 回归分析显示,E(B)反应是肾功能衰竭的独立危险因素(危险比=6.91,P=0.02)。各组对非 E(AB)的识别率仍然较低。在连续血清样本中未显示表位谱的扩增。
人类抗肾小球基底膜病发病前可能发生分子内表位扩展。针对 E(A)和 E(B)的自身免疫,尤其是 E(B),对肾功能障碍至关重要。